Importantly, miR-155 down-regulation simultaneously with BMP + TGF-β1 treatment had increasing and synergistic effects on reducing the proliferation rate of CD34+ CML cells (Figure 4(Fig. 4)). Here, CD34 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.